| 000 | 01761 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515090145.0 | ||
| 264 | 0 | _c20071109 | |
| 008 | 200711s 0 0 eng d | ||
| 022 | _a0165-4608 | ||
| 024 | 7 |
_a10.1016/j.cancergencyto.2007.06.001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAndrieux, Joris | |
| 245 | 0 | 0 |
_aBone morphogenetic protein antagonist gene NOG is involved in myeloproliferative disease associated with myelofibrosis. _h[electronic resource] |
| 260 |
_bCancer genetics and cytogenetics _cOct 2007 |
||
| 300 |
_a11-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aBone Morphogenetic Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aCarrier Proteins _xphysiology |
| 650 | 0 | 4 | _aChromosomes, Human, Pair 17 |
| 650 | 0 | 4 | _aChromosomes, Human, X |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Expression Regulation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMyeloproliferative Disorders _xgenetics |
| 650 | 0 | 4 |
_aOsteosclerosis _xgenetics |
| 650 | 0 | 4 |
_aPrimary Myelofibrosis _xgenetics |
| 650 | 0 | 4 | _aTranslocation, Genetic |
| 700 | 1 | _aRoche-Lestienne, Catherine | |
| 700 | 1 | _aGeffroy, Sandrine | |
| 700 | 1 | _aDesterke, Christophe | |
| 700 | 1 | _aGrardel, Nathalie | |
| 700 | 1 | _aPlantier, Isabelle | |
| 700 | 1 | _aSelleslag, Dominik | |
| 700 | 1 | _aDemory, Jean-Loup | |
| 700 | 1 | _aLaï, Jean-Luc | |
| 700 | 1 | _aLeleu, Xavier | |
| 700 | 1 | _aLe Bousse-Kerdiles, Caroline | |
| 700 | 1 | _aVandenberghe, Peter | |
| 773 | 0 |
_tCancer genetics and cytogenetics _gvol. 178 _gno. 1 _gp. 11-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.cancergencyto.2007.06.001 _zAvailable from publisher's website |
| 999 |
_c17412883 _d17412883 |
||